Identifying a mechanism responsible for altering microbial communities opens the door to the development of new therapies designed to interrupt the chain of events that give these pathogens a growth advantage after antibiotic treatments, the researchers said.
"Research has traditionally focused on the mechanisms by which antibiotics help control the growth of bacteria or inform the development of new formulations when bacteria become resistant to existing drugs," said Franziska Faber, from the University of California, Davis (UC Davis).
Gastroenteritis is a common side effect of taking antibiotics.
While diarrhoea may be mild and clear up after antibiotic therapy is completed, in some cases, it can lead to colitis, an inflammation of the colon, or more serious conditions that cause abdominal pain, fever and bloody diarrhoea.
Researchers found that oral antibiotic treatment increased the synthesis of a host enzyme that generates nitric oxide radicals, which can oxidise sugars into sugar acids, such as galactarate, a key driver of Salmonella growth.
"The new study suggests that this property is part of a 'business plan' Salmonella uses to grow in the host intestine," he said.
The study was published in the journal Nature.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
